Related Experiment Video
Updated: Mar 11, 2026

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos
Published on: December 13, 2018
Long Noncoding RNA-LET Suppresses Tumor Growth and EMT in Lung Adenocarcinoma
Bin Liu1, Chun-Feng Pan1, Zhi-Cheng He1
1Department of Thoracic and Cardiovascular Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, China.
Abstract:
Recently, many studies showed that long noncoding RNAs (lncRNAs) are involved in tumor progression. It is reported that lncRNA-LET is downregulated and has antitumor effect on several types of cancer. This study focuses on the role of lncRNA-LET on lung adenocarcinoma (LAC) progression. RT-PCR results indicated that frequent downregulation of lncRNA-LET in LAC tissues was related to clinicopathologic factors. lncRNA-LET knockdown significantly promoted LAC cell proliferation, invasion, and migration while lncRNA-LET overexpression obviously inhibited LAC cell proliferation, invasion, and migration, indicating a tumor inhibition of lncRNA-LET in LAC progression. Besides, lncRNA-LET inhibited EMT and negatively regulated Wnt/β-catenin pathway in part. Our study suggests that lncRNA-LET exhibits an important tumor-suppressive effect on LAC progression by inhibiting EMT and Wnt/β-catenin pathway, which provides potential therapeutic targets for LAC.
Insights
Long non-coding RNA-LET (lncRNA-LET) acts as a tumor suppressor in lung adenocarcinoma (LAC). Downregulation of lncRNA-LET promotes LAC progression, while its overexpression inhibits cancer growth by affecting EMT and the Wnt/β-catenin pathway.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Long noncoding RNAs (lncRNAs) are increasingly recognized for their roles in cancer development.
- lncRNA-LET has been previously identified as downregulated with antitumor effects in various cancers.
Purpose of the Study:
- To investigate the specific role and mechanism of lncRNA-LET in the progression of lung adenocarcinoma (LAC).
Main Methods:
- Reverse Transcription Polymerase Chain Reaction (RT-PCR) was used to analyze lncRNA-LET expression in LAC tissues.
- Functional assays were performed to assess the effects of lncRNA-LET knockdown and overexpression on LAC cell proliferation, invasion, and migration.
- The impact of lncRNA-LET on Epithelial-Mesenchymal Transition (EMT) and the Wnt/β-catenin pathway was evaluated.
Main Results:
- Frequent downregulation of lncRNA-LET was observed in LAC tissues and correlated with clinicopathologic factors.
- lncRNA-LET knockdown accelerated LAC cell proliferation, invasion, and migration.
- Overexpression of lncRNA-LET suppressed LAC cell proliferation, invasion, and migration, indicating an antitumor role.
- lncRNA-LET was found to inhibit EMT and negatively regulate the Wnt/β-catenin pathway.
Conclusions:
- lncRNA-LET functions as a tumor suppressor in lung adenocarcinoma.
- lncRNA-LET inhibits LAC progression by suppressing EMT and the Wnt/β-catenin pathway.
- lncRNA-LET represents a potential therapeutic target for lung adenocarcinoma treatment.
Related Concept Videos
lncRNA - Long Non-coding RNAs
lncRNA - Long Non-coding RNAs
MicroRNAs
MicroRNAs
Non-LTR Retrotransposons
Types of RNA
RNA Performs Diverse...